Article
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment
2025-11-24
Abstract excerpt
<h4>ABSTRACT</h4> While immunotherapy has become the standard of care for lung adenocarcinoma (LUAD) patients without actionable genomic alterations, only a subset of patients benefits from a long-lasting response to immunotherapy. Activation of p53-related signals has emerged as a potential mediator of the lung tumor microenvironment (TME). Given that mutant-p53 interacts with p73 extensively and TAp73-deficient...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1ba71055-a2b9-5080-8eb8-b82a8e1be531
- DOI
- 10.1101/2025.11.21.689807
